Evidium has announced the close of a $22 million Series A funding round as the company expands its healthcare AI platform focused on computational medical knowledge and transparent clinical reasoning. The round was co-led by Health2047, the venture studio founded by the American Medical Association, and WGG Partners, with participation from Interwoven Ventures and Mindset Ventures.
The company is developing AI that transforms clinical knowledge into computational models that can be validated, traced, and applied across care delivery and insurance environments. Evidium plans to use the new funding to accelerate product development and deepen its clinical modeling capabilities, while also scaling its go-to-market operations. The company is preparing strategic hires in AI research engineering, clinical science, and business development in response to increasing demand from health plans and provider organizations.
The company is focused on making medical knowledge observable and computational, enabling healthcare leaders to understand better patient journeys, forecast clinical trajectories and costs, and improve outcomes. Evidium is expanding its set of precision products, built on a shared modeling foundation, which includes insights tools for clinicians and care teams, as well as probabilistic forecasting solutions for medical risk-bearing organizations, such as insurers, health plans, and integrated delivery networks.
The company’s platform provides transparent and traceable reasoning, allowing users to audit how insights are generated. This approach supports faster learning cycles and knowledge sharing, while also augmenting other emerging AI tools with clinically grounded logic. Evidium is also broadening its offerings to additional healthcare segments, including life sciences and broader payer-provider ecosystems.
KEY QUOTES:
“Healthcare runs on knowledge, but until now, much of that knowledge has been locked in text, statistics, and silos. We’re solving this challenge by making medical knowledge computational and AI more reliable. Enabling healthcare leaders to see opportunities for improvement more clearly, reason more precisely, and share timely insights. This shared foundation helps experts across the system.”
Carl Bate, Founder and CEO of Evidium
“Healthcare’s future depends on systems that can learn, explain, and enhance the role of physicians. Evidium is advancing that kind of system—one where knowledge isn’t trapped in charts or claims data but continuously refined through use.”
Lawrence K. Cohen, CEO of Health2047
“Evidium’s substrate powers how AI systems reason in high-stakes domains – delivering a new class of reliable and precision insights healthcare leaders can act on.”
Herb Madan, WGG Partners
“Healthcare is a knowledge-driven industry where the accessibility and integrity of that knowledge directly impacts outcomes and costs. As a first principles team, we’ve focused on knowledge integrity from day one.”
Carl Bate, Founder and CEO of Evidium
“Building on our strong quality insights and performance record with health systems, we are now harnessing Evidium’s platform with insurers and others across the risk spectrum.”
Rajiv Sood, General Manager of Insurance and Risk at Evidium
“Our customers are provided with non-black-box insights in support of their work – every prediction and insight is fully traceable back to the clinical evidence and logic that produced it. In turn, enabling faster learning cycles and knowledge diffusion. Our products augment existing tools including generative AI with clinically grounded, fully transparent logic.”
Evidium company statement
